A citation-based method for searching scientific literature

Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, Jean-Claude Tardif, Subodh Verma, Christie M Ballantyne. Circulation 2021
Times Cited: 26



Deepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Michael Miller, Jean-Claude Tardif, Steven B Ketchum, Ralph T Doyle, Sabina A Murphy, Paresh N Soni, Rene A Braeckman, Rebecca A Juliano, Christie M Ballantyne. Clin Cardiol 2017
Times Cited: 114




List of shared articles



Times cited

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle,[...]. J Am Heart Assoc 2022
3

Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT.
Prakriti Gaba, Deepak L Bhatt, R Preston Mason, Michael Miller, Subodh Verma, Ph Gabriel Steg, William E Boden. J Clin Lipidol 2022
0

Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
Prakriti Gaba, Deepak L Bhatt, Robert P Giugliano, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. J Am Coll Cardiol 2021
10

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Arjun Majithia, Deepak L Bhatt, Allon N Friedman, Michael Miller, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. Circulation 2021
7

Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Subodh Verma, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Nitish K Dhingra, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. Circulation 2021
9

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Jordan B King, Brandon K Bellows, Gabriel S Tajeu, Catherine G Derington,[...]. JAMA Netw Open 2022
3

The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularization.
Ram D Bhatt, Peter Libby, Subodh Verma, R Preston Mason, Deepak L Bhatt. Prog Cardiovasc Dis 2021
6

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
Prakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle,[...]. J Am Coll Cardiol 2022
5

Marine-derived n-3 fatty acids therapy for stroke.
Celia Gabriela Alvarez Campano, Mary Joan Macleod, Lorna Aucott, Frank Thies. Cochrane Database Syst Rev 2022
0

The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl.
Catherine G Derington, Adam P Bress, Jennifer S Herrick, Wenjun Fan, Nathan D Wong, Katherine E Andrade, Jonathan Johnson, Sephy Philip, David Abrahamson, Lixia Jiao,[...]. Am J Prev Cardiol 2022
0